This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LIVE Online Course Running Again in November 2024

LIVE Online Course Running Again in November 2024

Thank You for attending Viral Vectors in Cell & Gene Therapies (& aspects of mRNA Therapeutics)

This course will run again in November 2024

Interested for your team to attend next year's course? Receive a group discount for registering a group of 3+

Contact Angel Huertas at to book your group today

Course Overview

This 3-day online course will detail the fundamental biological components for gene therapy and gene-modified cell therapies and outline important consideration for selecting the most appropriate vectors and specific safety aspects.

Critical biological information to enable understanding of the cell and gene therapy tools and therapies both existing today and coming in the near future.

The course will also address key points in manufacturing, purification and different technologies for each of the types of therapies addressed during the course.

The lack of standardization regarding modular single-use consumables will be discussed as well as methods for cell separation and scaling-up issues.

Participants will also be given a set of case studies to analyse from the perspective of the course and provide feedback to the course leader who will select a few for general forum viewing after anonymizing the person providing the analysis.

What will you learn?

Current and Emerging Therapies

From vaccines and antibody therapeutics to cell & gene technologies – gain insight into the latest emerging trends, their applications and future potential.

Cell & Gene Therapy Introduction

Learn about the key definitions, science and technologies behind today's growing cell & gene therapy market.

Underlying virology

Understand why viruses are used to engineer and deliver gene-modified cell and gene therapies


Familiarize yourself with how viral vectors are engineered, and how this translates into purification techniques

Viral vector selection

Consider important factors for selecting the most appropriate vector for your product, including gene size and transfection efficiency

Purification requirements

Understand how purification requirements, such as host cell DNA and residual empty capsids, are influenced by vector manufacture and end-use application, compare how these requirements differ between gene therapy and gene-modified cell therapies

Purification techniques

Appreciate that specific purification techniques are influenced by specific purification requirements of your product, then consider the different tests available to assess purification including qPCR, ELISA and TC1D50

Who is this course for?

This course is directly applicable to people working on the manufacturing of gene therapies and gene-modified cellular therapies. Relevant departments will include:

  • Gene Therapy Process Development
  • Cell Therapy Engineering
  • Cell Therapy Process Development
  • Quality Control/Assurance
  • Regulatory Affairs
  • Final Release Testing